BWP
GILD icon

Balboa Wealth Partners’s Gilead Sciences GILD Stock Holding History

Balboa Wealth Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$220K Sell
1,742
-1,315
-43% -$173K 0.03% 419
2026
Q1 		$426K Buy
3,057
+79
+3% +$11.1K 0.07% 230
2025
Q4 		$366K Buy
+2,978
New +$362K 0.06% 240
2025
Q2 		– Sell
-2,087
Closed -$234K – 389
2025
Q1 		$234K Buy
+2,087
New +$215K 0.06% 238
2024
Q2 		– Sell
-3,514
Closed -$257K – 316
2024
Q1 		$257K Sell
3,514
-66
-2% -$5.08K 0.08% 185
2023
Q4 		$290K Sell
3,580
-267
-7% -$20.8K 0.1% 166
2023
Q3 		$288K Sell
3,847
-447
-10% -$34.4K 0.11% 163
2023
Q2 		$331K Sell
4,294
-1,487
-26% -$119K 0.12% 148
2023
Q1 		$480K Sell
5,781
-696
-11% -$57.6K 0.18% 114
2022
Q4 		$556K Sell
6,477
-15,580
-71% -$1.23M 0.25% 101
2022
Q3 		$1.36M Buy
+22,057
New +$1.39M 0.6% 31

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Balboa Wealth Partners's GILD Position: Q2 2026 in Review

Balboa Wealth Partners reduced its Gilead Sciences (GILD) stake by 43% in Q2 2026, selling an estimated $173K and leaving 1,742 shares worth $220K. The position accounts for 0.03% of the portfolio, ranked #419.

Balboa Wealth Partners first reported a position in GILD in Q3 2022 and has held it in 11 quarters since. The position peaked at $1.36M in Q3 2022. 2,287 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Balboa Wealth Partners held 1,742 shares of Gilead Sciences worth $220K as of Q2 2026.
  • Balboa Wealth Partners sold 1,315 Gilead Sciences shares in Q2 2026, an estimated $173K.
  • Gilead Sciences made up 0.03% of Balboa Wealth Partners's portfolio in Q2 2026, its #419 holding.
  • Balboa Wealth Partners first reported a position in Gilead Sciences in Q3 2022 and has held it in 11 quarters since.
  • Balboa Wealth Partners's Gilead Sciences position peaked at $1.36M in Q3 2022.
  • 2,287 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Balboa Wealth Partners's 13F filing for Q2 2026, filed 10 Aug 2026.